eFFECTOR Therapeutics, Inc. (EFTR)
NASDAQ: EFTR · IEX Real-Time Price · USD
0.180
-0.087 (-32.56%)
At close: Jul 2, 2024, 4:00 PM
0.155
-0.025 (-13.89%)
After-hours: Jul 2, 2024, 7:59 PM EDT
eFFECTOR Therapeutics Market Cap
eFFECTOR Therapeutics has a market cap or net worth of $846.79 thousand as of July 2, 2024. Its market cap has decreased by -97.59% in one year.
Market Cap
846.79K
Enterprise Value
-4.29M
1-Year Change
-97.59%
Ranking
Category
Stock Price
$0.18
Market Cap Chart
Since January 8, 2021, eFFECTOR Therapeutics's market cap has decreased from $175.80M to $846.79K, a decrease of -99.52%. That is a compound annual growth rate of -78.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 1.30M | -95.70% |
| Dec 29, 2023 | 30.20M | 68.72% |
| Dec 30, 2022 | 17.90M | -94.65% |
| Dec 31, 2021 | 334.30M | 90.16% |
| Jan 8, 2021 | 175.80M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 180 Life Sciences | 1.55M |
| Salarius Pharmaceuticals | 1.42M |
| Virpax Pharmaceuticals | 1.42M |
| NeuBase Therapeutics | 1.42M |
| Dynatronics | 1.41M |
| Bone Biologics | 1.34M |
| LogicMark | 1.34M |
| Aptevo Therapeutics | 1.25M |